Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Other Non-Current Assets (2016 - 2026)

Mimedx's Other Non-Current Assets history spans 16 years, with the latest figure at $6.9 million for Q1 2026.

  • On a quarterly basis, Other Non-Current Assets rose 557.06% to $6.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was $6.9 million, a 557.06% increase, with the full-year FY2025 number at $7.3 million, up 8.37% from a year prior.
  • Other Non-Current Assets hit $6.9 million in Q1 2026 for Mimedx, down from $7.3 million in the prior quarter.
  • Over the last five years, Other Non-Current Assets for MDXG hit a ceiling of $7.3 million in Q4 2025 and a floor of $146000.0 in Q2 2023.
  • Historically, Other Non-Current Assets has averaged $1.9 million across 5 years, with a median of $1.0 million in 2025.
  • Biggest five-year swings in Other Non-Current Assets: tumbled 89.01% in 2023 and later surged 3174.15% in 2024.
  • Tracing MDXG's Other Non-Current Assets over 5 years: stood at $1.9 million in 2022, then tumbled by 89.01% to $205000.0 in 2023, then surged by 3174.15% to $6.7 million in 2024, then grew by 8.37% to $7.3 million in 2025, then fell by 5.33% to $6.9 million in 2026.
  • Business Quant data shows Other Non-Current Assets for MDXG at $6.9 million in Q1 2026, $7.3 million in Q4 2025, and $3.0 million in Q3 2025.